End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
69.9 TWD | -0.14% | +1.16% | +7.87% |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.24 for the current year.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an enterprise value anticipated at 4.03 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.87% | 28.18B | A | ||
+10.67% | 102B | B- | ||
+5.68% | 100B | B | ||
-9.99% | 89.53B | B+ | ||
+10.71% | 70.76B | D+ | ||
+14.17% | 32.05B | B | ||
+19.45% | 29.03B | B | ||
+1.23% | 17.28B | C+ | ||
-14.59% | 14.3B | B | ||
+8.03% | 9.91B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2881 Stock
- Ratings Fubon Financial Holding Co., Ltd.